💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Will Assai Continue To Drive Growth At Companhia Brasileira?

Published 11/30/2017, 08:41 PM
Updated 07/09/2023, 06:31 AM
ROST
-
WMT
-
DG
-
CBD
-

Companhia Brasileira de Distribuicao (NYSE:CBD) has seen its shares rally 50.4% over a year, in comparison with the industry’s surge of 32.4%. While the company has been gaining from continued market share gains at its Assai and Multivarejo segments, we believe that Assai remains its major growth driver. So, let’s delve deeper into these factors and see if they can continue to drive Companhia Brasileira amid a tough Brazilian environment.





Assai: A Major Growth Driver

Companhia Brasileira’s Assai segment, which has long been the company’s major growth driver, remained the highlight of its third-quarter 2017 performance as well. Notably this quarter marked Assai’s strongest quarter of combined volume and traffic growth in the recent times. In the third quarter, sales at this segment surged 25.2%, adjusted for the calendar effect. The sturdy growth was driven by higher comps and contributions from new stores.

Despite major food deflation in some key categories, Assai’s comps grew 7.7%, on the back of improved customer traffic and sales volume. Further, Assai contributed about 43% to the company’s total food sales, marking 600 bps growth from the year-ago period. Also, the segment witnessed market share gains of 330 bps year over year. Notably, management remains committed toward converting Extra Hiper stores into Assai stores, to optimize its portfolio. This clearly reflects robust prospects from this segment.

Apart from Assai, the company has also been gaining from improved volumes of Pao de Acucar and consistent recovery at Extra Hiper, which have been driving its Multivarejo segment. Evidently, the company’s third-quarter sales jumped 8.1% (adjusted for calendar effect), with comps rising at both segments. Also, adjusted EBITDA jumped 11.4%, with the EBITDA margin expanding 20 bps to 5%, fueled by improvements at both Multivarejo and Assai. For 2017 too, management envisions Food segment EBITDA margin of approximately 5.5%, backed by greater profitability at both divisions.

Further, the company remains focused on enhancing its food business, by making investments in Assai and Pao de Acucar, which are yielding solid returns. All said, the company anticipates continued market share gains at both its segments.

While macroeconomic headwinds in the Brazilian retail space and stiff competition in the appliances business may act as deterrents, we believe that strength in Assai is likely to help this Zacks Rank #3 (Hold) stock sustain its momentum.

Looking for More Promising Stocks? Check These

Wal-Mart Stores Inc. (NYSE:WMT) , with a Zacks Rank #2 (Buy) flaunts a splendid earnings surprise history. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Dollar General Corporation (NYSE:DG) carrying a Zacks Rank #2 has an impressive long-term earnings growth rate of 11.3%.

Ross Stores, Inc. (NASDAQ:ROST) delivered an average positive earnings surprise of 5.5% in the trailing four quarters and has a long-term earnings growth rate of 10%. The company carries the same Zacks Rank as Dollar General.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



Wal-Mart Stores, Inc. (WMT): Free Stock Analysis Report

Dollar General Corporation (DG): Free Stock Analysis Report

Ross Stores, Inc. (ROST): Free Stock Analysis Report

Companhia Brasileira de Distribuicao (CBD): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.